
Konzernumbau und Glyphosat: Bayer ist „noch lange nicht am Ziel“
Der Pharma- und Agrarchemiekonzern kommt in seinen Rechtsstreitigkeiten rund um Glyphosat zwar voran – doch lastet der Monsanto-Kauf weiter mit Milliardensummen auf der Bilanz.
7 stories found

Der Pharma- und Agrarchemiekonzern kommt in seinen Rechtsstreitigkeiten rund um Glyphosat zwar voran – doch lastet der Monsanto-Kauf weiter mit Milliardensummen auf der Bilanz.
German pharmaceutical giant Bayer has proposed a $7.25 billion settlement to resolve claims in the US alleging that Monsanto's Roundup weedkiller causes cancer.

Bayer has offered $7.25 billion to settle numerous legal claims alleging that its Roundup weedkiller, inherited from Monsanto, causes cancer.

Bayer reports significant financial losses, driven deep into the red by ongoing legal disputes related to its glyphosate-based products, stemming from its acquisition of Monsanto.
Former President Trump has invoked the Defense Act concerning Monsanto chemicals, leading to phosphorus being designated as a critical mineral, which is expected to impact Bayer and agribusiness ETFs.

A report from Nova ekonomija highlights that the potentially carcinogenic herbicide glyphosate, produced by Bayer and Monsanto, is easily accessible for purchase in Serbia, even by children. This comes as Bayer and Monsanto are reportedly settling lawsuits related to Roundup (glyphosate) for $7.2 billion.

German chemical giant Bayer has reached a proposed $7.25 billion settlement over lawsuits claiming that glyphosate in its Roundup weedkiller causes cancer.